Wu, HangjianGazzard, GusKing, AnthonyMorgan, JamesWright, DavidCrabb, David P.Takwoingi, YemisiAzuara-Blanco, AugustoWatson, VerityHernández, Rodolfo2024-10-172024-10-172024-08-28Wu, H, Gazzard, G, King, A, Morgan, J, Wright, D, Crabb, D P, Takwoingi, Y, Azuara-Blanco, A, Watson, V & Hernández, R 2024, 'Cost-effectiveness of monitoring ocular hypertension based on a risk prediction tool', BMJ open ophthalmology, vol. 9, no. 1, e001741. https://doi.org/10.1136/bmjophth-2024-0017412397-3269ORCID: /0000-0003-2619-8230/work/170011187https://hdl.handle.net/2164/24425We are thankful to Christopher Cardwell who provided extensive statistical assistance. We are grateful for the ongoing support of the project management group and patient representatives.9799481engGlaucomaOcular HypertensionQuality-Adjusted Life YearsAntihypertensive Agents/therapeutic useRisk AssessmentHumansMiddle AgedRisk FactorsOcular Hypertension/economicsMaleUnited Kingdom/epidemiologyIntraocular Pressure/physiologyCost-Benefit AnalysisHealth Care Costs/statistics & numerical dataFemaleAgedOphthalmologyJournal article10.1136/bmjophth-2024-001741http://www.scopus.com/inward/record.url?scp=85203113266&partnerID=8YFLogxK91